Mary Retzlaff | Chief Science Officer
Ambient Biosciences

Mary Retzlaff, PhD, is the Chief Scientific Officer at Ambient Biosciences. She earned her doctorate in Chemistry from the University of Illinois Urbana–Champaign. Prior to joining Ambient, Mary spent 20 years at Merck Research Laboratories in Bioprocess R&D, where she led teams responsible for analytical, process, and formulation development; CMC filings; and technology transfer for vaccines across Merck’s pipeline. At Ambient Biosciences, Mary now guides the scientific strategy behind the company’s novel stabilization technology for biomolecules—an innovation designed to enhance the stability of analytical reagents, clinical and diagnostic samples, biotherapeutics and vaccines and to eliminate the need for cold-chain storage and distribution.

Appearances:

Day 1 - Tuesday 31st March @ 13:30

5-Minute Presentations - Innovator Showcase

1:30 "TITLE TBD" - Dr Yimy Mena, CEO, Pegasus Biotech

1:35 - "Precision Virology Products for Advanced R&D and Product Manufacturing" Dr Nishank Bhala, Senior Scientist/Co-founder, Advanced Virology

1:40 - “Reinventing Stability: A Simplified Approach for Vaccines, Biotherapeutics, and Critical Reagents” Mary Retzlaff, CSO, Ambient Biosciences

1:45 "TITLE TBD" - Adam Brown, CEO & Founder, Quansys Biosciences

1:50 - "Fixing the Data Handoffs That Slow Drug Development" Justin Byers, CEO, Axio BioPharma

1:55 "TITLE TBD" - Robert Forgey, President & CEO, IASO Therapeutics

2:00 "TITLE TBD" - Dr Samuel Wu, CBO, Blue Lake Biotechnology

2:05 "TITLE TBD" - Dr David Anderson, Founder, Phoenix Therapeutics

Yimy Mena, CEO and Director of Process Development, Pegasus Biotech Inc.